Shares of Victrex plc (LON:VCT - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,004.35 ($12.36) and traded as high as GBX 1,058 ($13.02). Victrex shares last traded at GBX 1,024 ($12.60), with a volume of 143,353 shares.
Wall Street Analyst Weigh In
Separately, Berenberg Bank decreased their target price on Victrex from GBX 1,290 ($15.87) to GBX 1,170 ($14.40) and set a "hold" rating on the stock in a research report on Wednesday, December 4th.
Read Our Latest Report on VCT
Victrex Stock Up 1.0 %
The company has a debt-to-equity ratio of 16.99, a current ratio of 5.30 and a quick ratio of 1.99. The business's 50 day moving average price is GBX 984.46 and its 200 day moving average price is GBX 1,003.44. The firm has a market cap of £899.89 million, a PE ratio of 2,954.29, a PEG ratio of 1.92 and a beta of 0.69.
Victrex Increases Dividend
The company also recently announced a dividend, which will be paid on Friday, February 21st. Shareholders of record on Thursday, January 23rd will be issued a dividend of GBX 46.14 ($0.57) per share. The ex-dividend date is Thursday, January 23rd. This represents a dividend yield of 5.26%. This is a boost from Victrex's previous dividend of $13.42. Victrex's dividend payout ratio is presently 17,142.86%.
Insider Buying and Selling at Victrex
In other Victrex news, insider Brendan Connolly acquired 980 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was bought at an average cost of GBX 1,019 ($12.54) per share, for a total transaction of £9,986.20 ($12,287.68). Also, insider Ian Melling acquired 2,000 shares of the business's stock in a transaction that occurred on Friday, December 13th. The shares were acquired at an average cost of GBX 1,135 ($13.97) per share, with a total value of £22,700 ($27,931.59). 1.64% of the stock is currently owned by insiders.
Victrex Company Profile
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Further Reading
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
